Psychedelic science update & harm reduction training for naturopathic physicians

Psychedelic science update & harm reduction training for naturopathic physicians

8 CONTINUING EDUCATION (CE) HOURS

FEBRUARY 1–4, 2027
OPIHIHALE ETHNOBOTANICAL PRESERVE
Big Island, Hawai‘i

$2,850

INCLUDES

Three nights lodging | All meals
Ground transportation to and from Kona Airport
Course materials | Guided ethnobotanical tour

AIMS Institute in collaboration with Opihihale Ethnobotanical Preserve


WHY THIS COURSE?

As interest in psychedelic therapies continues to grow, naturopathic physicians are increasingly asked about their safety, effectiveness, legal status, and appropriate clinical use. This immersive continuing education program provides an evidence-based review of current psychedelic science together with practical harm reduction strategies for clinicians whose patients are considering or using psychedelic medicines.

Presented by the AIMS Institute in collaboration with the Opihihale Ethnobotanical Preserve, participants will combine classroom learning with hands-on botanical education in one of Hawai‘i’s unique rainforest environments.


CURRICULUM – 8 CE HOURS

1. CLINICAL RESEARCH UPDATE (2 HOURS)

Review current evidence involving MDMA, psilocybin, ketamine, DMT, 5-MeO-DMT, ibogaine, mescaline, LSD, and emerging therapeutic applications.

2. NEUROBIOLOGY & PHARMACOLOGY (2 HOURS)

Mechanisms of action, neurochemistry, therapeutic potential, contraindications, and the evolving regulatory landscape.

3. CLINICAL HARM REDUCTION (2 HOURS)

Practical guidance for physicians counseling patients considering psychedelic therapies, including screening, safety assessment, preparation, contraindications, and integration.

4. ETHNOBOTANICAL PRACTICUM (2 HOURS)

Guided field experience through the Opihihale Ethnobotanical Preserve featuring traditional and contemporary medicinal plants including Banisteriopsis caapi, Psychotria viridis, Psilocybe species, Echinopsis pachanoi (San Pedro), Salvia divinorum, and other ethnobotanical specimens.

This course has been approved for 8 credits of Naturopathic Continuing Education through the American Association of Naturopathic Physicians.


SCHEDULE

SUNDAY • JANUARY 31

Participants travel from Kaua‘i following Hawai‘i Doc Talks.

MONDAY–WEDNESDAY

FEBRUARY 1–3, 2027

Lectures, discussion, rainforest practicum, lodging, and meals.

THURSDAY • FEBRUARY 4

Morning transportation to Kona International Airport.

Enrollment limited to 10 physicians to encourage discussion and individualized instruction.


FACULTY

LEANNA STANDISH, ND, PhD, FABNO

Co-Director, AIMS Institute

Neuroscientist and naturopathic physician who studies psychedelic natural medicines. World renowned speaker on ayahuasca research, history, neurochemistry and clinical trial design. Previously taught the Bastyr University graduate course in Psychedelic Science, History, and Culture. AIMS Institute has provided ketamine-assisted psychotherapy to patients with chronic disease since 2018.

DONA ELAM, PA

Psychiatric Physician Associate

Experienced psychiatric clinician with 30 years of practice. Provides care at AIMS Institute and has extensive experience in psychedelic preparation, harm reduction, guidance, and integration.


LOCATION

Opihihale Ethnobotanical Preserve

Captain Cook,
Hawai‘i Island

Nestled within an old-growth Hawaiian rainforest, the preserve provides a unique setting for botanical education and experiential learning.


REGISTRATION

$2,850

Includes lodging, meals, airport transportation, course materials, and guided ethnobotanical practicum.

LIMITED TO
10 PARTICIPANTS

SCAN TO REGISTER

info@aimsinstitute.org

Latest Blog Posts

Supporting women in the wild with science and wisdom about psychedelics.

Supporting women in the wild with science and wisdom about psychedelics.

Supporting women in the wild with science and wisdom about psychedelics. 134. Psychedelics and Grief: When Containment Stops Working Dr. Sunil Aggarwal joins April Pride to talk psilocybin, grief, and the difference between containing a loss and integrating it. April Pride Sep 29 Recently, it occurred to me that my relationship with trust needed tending. When I told a friend, she asked, “Why don’t you trust yourself?” I’ve been sitting with that question because it tracks and it confuses me at the same time. I’ve walked into divorce, entrepreneurship, and work in the Schedule I-adjacent world. Not the choices of ...

Read More
Watch now: Psychedelics and Grief: When Containment Stops Working

Watch now: Psychedelics and Grief: When Containment Stops Working

How Academy Members Are Integrating Psychedelics to Ease Distress Catherine Arnold For patients facing serious illness, some of the deepest suffering cannot be measured on a numerical scale.  Some patients experience anxiety that does not respond to conventional treatment, as well as a deep sense of demoralization, isolation, and loss of meaning. Palliative and hospice care have long recognized treatment of this existential distress as central to whole-person care. Now, an emerging field of research is asking whether psychedelic-assisted therapy (PAT)—a structured protocol that combines the administration of a psychoactive compound with guided professional psychotherapy before, during, and after the ...

Read More
Psychedelic science update & harm reduction training for naturopathic physicians

Psychedelic science update & harm reduction training for naturopathic physicians

8 CONTINUING EDUCATION (CE) HOURS FEBRUARY 1–4, 2027OPIHIHALE ETHNOBOTANICAL PRESERVEBig Island, Hawai‘i $2,850 INCLUDES Three nights lodging | All mealsGround transportation to and from Kona AirportCourse materials | Guided ethnobotanical tour AIMS Institute in collaboration with Opihihale Ethnobotanical Preserve WHY THIS COURSE? As interest in psychedelic therapies continues to grow, naturopathic physicians are increasingly asked about their safety, effectiveness, legal status, and appropriate clinical use. This immersive continuing education program provides an evidence-based review of current psychedelic science together with practical harm reduction strategies for clinicians whose patients are considering or using psychedelic medicines. Presented by the AIMS Institute in ...

Read More

Accessibility Tools

Increase TextIncrease Text
Decrease TextDecrease Text
GrayscaleGrayscale
Invert Colors
Readable FontReadable Font
Reset
Call Us Text Us